PRJNA615206 - An open-label, phase II basket study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors - OmicsDI

Genomics

Dataset Information

An open-label, phase II basket study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors

ABSTRACT: An open-label, phase II basket study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors

PROVIDER: PRJNA615206 | ENA |

REPOSITORIES: ENA